<DOC>
	<DOC>NCT00739674</DOC>
	<brief_summary>To evaluate the effectiveness of diet management with a losartan based titration regimen versus losartan based titration regimen alone on blood pressure reduction in hypertensive patients.</brief_summary>
	<brief_title>SAALT: Subtracting Salt and Adding Losartan Trial (0954A-335)</brief_title>
	<detailed_description />
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<mesh_term>Calcium Channel Blockers</mesh_term>
	<criteria>Non Diabetic, Newly Diagnosed And Untreated For Mild To Moderate Hypertension (blood pressure &gt; 161; &lt; 221; 140/90 mm Hg But &lt; 180/110 mm Hg) Non diabetic, newly diagnosed and untreated for severe hypertension (blood pressure &gt; 180/110 mm Hg but &lt; 200/120 mm Hg); Patients who are asymptomatic with no evidence of significant end organ damage including direct pressure effects can be included. Patients in an urgency/emergency state are to be excluded Or Diabetic, Newly Diagnosed With Hypertension And Untreated With Mild To Moderate Hypertension (blood pressure &gt; 161;&lt; 221; 130/80 mm Hg But &lt; 160/100 mm Hg); Or Patient Receiving One Antihypertensive Agent (Monotherapy Only) Used To Treat Hypertension For At Least 4 Weeks And Whose Blood Pressure Is Not Controlled: blood pressure &gt; 161;&lt; 221; 140/90 mm Hg But &lt; 160/100 mm Hg Or For Diabetic And/Or Coronary Artery Disease Patients: blood pressure &gt; 161;&lt; 221; 130/80 mm Hg But &gt; 161;&lt; 221; 150/90 mm Hg The Antihypertensive Agent Will Need To Be Discontinued Prior To Starting Study Drug Known Secondary Hypertension Of Any Aetiology (E.G., Uncorrected Renal Artery Stenosis, Malignant Hypertension, Hypertensive Encephalopathy. Patient With Symptomatic Heart Failure (Classes 3 And 4). Patient With A Prior Myocardial Infarction Or Stroke Within The Last 6 Months Patient Has Undergone Percutaneous Coronary Angioplasty, Has Had Coronary Artery Bypass Within The Last 6 Months Or Has Unstable Angina Patient With Anuria Or Confirmed Clinically Significant Renal Or Hepatic Dysfunction (Taken From Current/Past Medical Records) And/Or Electrolyte Imbalance Laboratory Test Within The Last 3 Months Prior To Visit 1: Serum Creatinine &gt; 130 ÃŒmol/L Or Creatinine Clearance &lt; 45 Ml/Min, Ast &gt; 3 Times Above The Normal Range, Alt &gt; 3 Times Above The Normal Range, Serum Potassium &lt; 3.5 Or &gt; 5.5 Meq/L Significant Liver Or Respiratory Disease, Cancer Or Other concomitant Disease That Is Likely To Affect Life Expectancy Of The Patient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>